![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/88 | |
C07C 321/14 | |||
C07C 235/06 | |||
C07C 271/16 | |||
C07C 275/06 | |||
A61K 9/127 | |||
A61K 47/48 | |||
A61K 48/00 | |||
A61K 31/7088 | |||
A61K 47/44 | |||
C07H 21/00 | |||
C07C 233/18 | |||
C07C 235/08 |
(11) | Number of the document | 1664316 |
(13) | Kind of document | T |
(96) | European patent application number | 04761838.4 |
Date of filing the European patent application | 2004-09-15 | |
(97) | Date of publication of the European application | 2006-06-07 |
(45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2004/001677 |
Date | 2004-09-15 |
(87) | Number | WO 2005/026372 |
Date | 2005-03-24 |
(30) | Number | Date | Country code |
503239 P | 2003-09-15 | US |
(72) |
HEYES, James, CA
MACLACHLAN, Ian, CA
AMBEGIA, Ellen Grace, CA
|
(73) |
Protiva Biotherapeutics Inc.,
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8,
CA
|
(54) | POLYETHYLENEGLYCOL-MODIFIED LIPID COMPOUNDS AND USES THEREOF |
POLYETHYLENEGLYCOL-MODIFIED LIPID COMPOUNDS AND USES THEREOF |